IL1B and neoplasm: Inactivation of NLRP3 inflammasome driven by miR-233-3p has been found to decrease the expression of NLRP3 inflammasome-associated proteins, ASC, IL-1β, and IL-18 in breast cancers and suppress tumor growth.